CSL Plasma Inc 3501 Cedar St Space 7
FDA inspection history in Philadelphia, Pennsylvania, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at Philadelphia, Pennsylvania.
Cited most
Across all CSL Plasma Inc 3501 Cedar St Space 7 observations on file
- 21 CFR 606.171Reporting of product deviations by licensed manufacturers, unlicensed registered blood establishments, and transfusion services1
- 21 CFR 640.64(e)Collection of blood for Source Plasma1
The complete CSL Plasma Inc 3501 Cedar St Space 7 file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Philadelphia, Pennsylvania
One Form 483 · 2026 · 2 observations
Latest: Form 483, Feb 6, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-02-06 | 483 Form 483 | Philadelphia, Pennsylvania | 2 | $99 |
Investigators on these documents
FEI number 3022099864 · most recent document Feb 6, 2026
About CSL Plasma Inc 3501 Cedar St Space 7
How many FDA Form 483s has CSL Plasma Inc 3501 Cedar St Space 7 received?
FDA Intel has 1 Form 483 on file for CSL Plasma Inc 3501 Cedar St Space 7; the most recent is dated Feb 6, 2026.
When was CSL Plasma Inc 3501 Cedar St Space 7 last inspected by FDA?
The most recent FDA inspection document on file for CSL Plasma Inc 3501 Cedar St Space 7 is a Form 483 dated Feb 6, 2026, for the site in Philadelphia, Pennsylvania.
What did FDA cite at CSL Plasma Inc 3501 Cedar St Space 7?
The regulations cited most in the observations on file for CSL Plasma Inc 3501 Cedar St Space 7 are 21 CFR 606.171 (Reporting of product deviations by licensed manufacturers, unlicensed registered blood establishments, and transfusion services), 1 time; 21 CFR 640.64(e) (Collection of blood for Source Plasma), 1 time.